tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

REGN Stock Latest News

Regeneron and Sanofi Advance Kevzara Into Polymyalgia Rheumatica, Eyeing New Growth Channel
Company AnnouncementsRegeneron and Sanofi Advance Kevzara Into Polymyalgia Rheumatica, Eyeing New Growth Channel
1d ago
SNY
REGN
Regeneron highlights expanding portfolio, pipeline at AAAI
PremiumThe Fly
Regeneron highlights expanding portfolio, pipeline at AAAI
2d ago
SNY
REGN
Regeneron price target raised to $975 from $865 at Guggenheim
PremiumThe Fly
Regeneron price target raised to $975 from $865 at Guggenheim
3d ago
REGN
Regeneron Targets Early Myeloma: New Phase 3 Trial Pits Linvoseltamab Against Daratumumab
PremiumCompany Announcements
Regeneron Targets Early Myeloma: New Phase 3 Trial Pits Linvoseltamab Against Daratumumab
5d ago
REGN
Regeneron’s REGN9533 Trial Completion Signals Quiet but Important Progress in Clot-Blocking Drugs
PremiumCompany Announcements
Regeneron’s REGN9533 Trial Completion Signals Quiet but Important Progress in Clot-Blocking Drugs
5d ago
REGN
Regeneron’s Expanding AI Use Raises Data Privacy, Regulatory and Market Risks
PremiumCompany AnnouncementsRegeneron’s Expanding AI Use Raises Data Privacy, Regulatory and Market Risks
7d ago
REGN
Regeneron Broadens Women’s Health Pipeline With New Phase 2 FHA Trial
Premium
Company Announcements
Regeneron Broadens Women’s Health Pipeline With New Phase 2 FHA Trial
7d ago
REGN
Regeneron price target raised to $800 from $740 at Cantor Fitzgerald
Premium
The Fly
Regeneron price target raised to $800 from $740 at Cantor Fitzgerald
9d ago
REGN
Regeneron price target raised to $742 from $630 at Baird
PremiumThe Fly
Regeneron price target raised to $742 from $630 at Baird
10d ago
REGN
Regeneron price target raised to $865 from $750 at Oppenheimer
PremiumThe Fly
Regeneron price target raised to $865 from $750 at Oppenheimer
10d ago
REGN
Regeneron announces upcoming presentations at Angiogenesis annual meeting
PremiumThe Fly
Regeneron announces upcoming presentations at Angiogenesis annual meeting
10d ago
REGN
Regeneron price target raised to $950 from $850 at JPMorgan
PremiumThe Fly
Regeneron price target raised to $950 from $850 at JPMorgan
10d ago
REGN
Regeneron price target raised to $800 from $745 at Wells Fargo
PremiumThe FlyRegeneron price target raised to $800 from $745 at Wells Fargo
10d ago
REGN
Regeneron price target raised to $769 from $768 at Morgan Stanley
Premium
The Fly
Regeneron price target raised to $769 from $768 at Morgan Stanley
10d ago
REGN
Balanced Risk/Reward Keeps Regeneron at Hold Amid Solid Fundamentals and Pipeline Uncertainty
Premium
Ratings
Balanced Risk/Reward Keeps Regeneron at Hold Amid Solid Fundamentals and Pipeline Uncertainty
10d ago
REGN
Regeneron’s Earnings Call: Growth Engines and Rising Costs
PremiumCompany Announcements
Regeneron’s Earnings Call: Growth Engines and Rising Costs
12d ago
REGN
Regeneron Pharmaceuticals: Robust 4Q25 Beat, Underappreciated Pipeline Upside, and 2026 Catalysts Support Buy Rating and $870 Target
PremiumRatings
Regeneron Pharmaceuticals: Robust 4Q25 Beat, Underappreciated Pipeline Upside, and 2026 Catalysts Support Buy Rating and $870 Target
12d ago
REGN
Regeneron price target raised to $870 from $820 at Raymond James
PremiumThe Fly
Regeneron price target raised to $870 from $820 at Raymond James
12d ago
REGN
Options Volatility and Implied Earnings Moves Today, January 30, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, January 30, 2026
13d ago
CL
VZ
Regeneron reports Q4 non-GAAP EPS $11.44, consensus $10.74
PremiumThe FlyRegeneron reports Q4 non-GAAP EPS $11.44, consensus $10.74
13d ago
REGN
Regeneron sees 2026 CapEx $1.3B
Premium
The Fly
Regeneron sees 2026 CapEx $1.3B
13d ago
REGN
Regeneron price target raised to $820 from $800 at TD Cowen
Premium
The Fly
Regeneron price target raised to $820 from $800 at TD Cowen
13d ago
REGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >